TY  - JOUR
PY  - 2016//
TI  - Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States
JO  - Journal of the American Academy of Dermatology
A1  - Danesh, Melissa J.
A1  - Kimball, Alexa B.
SP  - 190
EP  - 192
VL  - 74
IS  - 1
N2  - <p>Brodalumab is a human monoclonal antibody developed by Amgen, Inc. to treat inflammatory diseases. In May 2015, Amgen announced that it was ending its participation in co-development of the compound because of reports of patients having "events of suicidal ideation and behavior"...</p>  <p>Language: en</p>
LA  - en
SN  - 0190-9622
UR  - http://dx.doi.org/10.1016/j.jaad.2015.08.057
ID  - ref1
ER  -